(Q40866988)

24 September 2017

title

Different sensitivity of the transforming growth factor-beta cell cycle arrest pathway to c-Myc and MDM-2. (English)

1 reference

24 September 2017

S W Blain

1

1 reference

24 September 2017

J Massagué

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

275

1 reference

24 September 2017

issue

41

1 reference

24 September 2017

page(s)

32066-32070

1 reference

TGF-beta signal transduction

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

p53-independent role of MDM2 in TGF-beta1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

mdm2: a bridge over the two tumour suppressors, p53 and Rb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Interaction between the retinoblastoma protein and the oncoprotein MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Human Smad3 and Smad4 are sequence-specific transcription activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Mysterious liaisons: the relationship between c-Myc and the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006496200

21 January 2018

Identifiers

DOI

10.1074/JBC.M006496200

1 reference

24 September 2017

1 reference